NC
Nirmal Chandra Sahu
About Nirmal Chandra Sahu
Data last updated:
Nirmal Chandra Sahu is a Director at Ncure Lab Private Limited (since 2025), Director at Hrn Hospitality Private Limited (since 2025) and Director at Virilebrio Pharmaceuticals Private Limited (since 2018). The companies operate in Consumer Services and Business Services.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 07 Aug 2025 | 2025 | Active | ||
| Director | 21 Jun 2025 | 2025 | Active | ||
| Director | 30 Jan 2018 | 2018 | Active |
Board colleagues of Nirmal Chandra Sahu
| Name | DIN | Company | Designation |
|---|---|---|---|
| Bhagya Laxmi Padhi | 11165488 | Ncure Lab Private Limited , Hrn Hospitality Private Limited | Director |
| Deepti Kar | 08040208 | Virilebrio Pharmaceuticals Private Limited | Director |
| Mangi Keshab Reddy | 08040209 | Virilebrio Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nirmal Chandra Sahu
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nirmal Chandra Sahu
Nirmal Chandra Sahu currently holds 3 directorships: Ncure Lab Private Limited (Director, since 07 Aug 2025); Hrn Hospitality Private Limited (Director, since 21 Jun 2025); Virilebrio Pharmaceuticals Private Limited (Director, since 30 Jan 2018).
Nirmal Chandra Sahu was first appointed on 30 Jan 2018 as Director at Virilebrio Pharmaceuticals Private Limited. The most recent appointment on record is 07 Aug 2025 at Ncure Lab Private Limited.
The current boards of Nirmal Chandra Sahu's companies include Bhagya Laxmi Padhi (Ncure Lab Private Limited), Deepti Kar (Virilebrio Pharmaceuticals Private Limited), Mangi Keshab Reddy (Virilebrio Pharmaceuticals Private Limited).